Erratum: Approach to early Barrett's cancer (World Journal of Surgery (September 2003) 27, 9 (1040-1046) DOI: 10.1007/s00268-003-7059-8);Approach to early Barrett's cancer

World Journal of Surgery

Volumn 27, Issue 9, 2003, Pages 1040-1046

  Stein, Hubert J ^a   Feith, Marcus ^a   Rahden, Burkhard A H V ^a   Siewert, J Rüdiger ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER CLASSIFICATION; CANCER SURVIVAL; CARCINOMA IN SITU; DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METAPLASIA; MORTALITY; PATHOLOGY; PRECANCER; PREVALENCE; SQUAMOUS CELL CARCINOMA; TIME; TREATMENT OUTCOME;

EID: 0141430872     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7059-8     Document Type: Erratum

References (38)

1. Spechler SJ. Barrett's esophagus. N. Engl. J. Med. 2002;346:836-842
2. Peters JH, Clark GW, Ireland AP. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J. Thorac. Cardiovasc. Surg. 1994;108:813-822
3. Van Sandick JW, van Lanschot JJ, Kuiken BW, et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-222
4. Stein HJ, Feith M, Müller J, et al. Limited resection for early Barrett's cancer. Ann. Surg. 2000;232:733-742
5. Nigro JJ, Hagen JA, DeMeester TR, et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann. Surg. 1999;230:433-438
6. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-677
7. Gossner L, May A, Stolte M, et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest. Endosc. 1999;49:8-12
8. Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448-455
9. Sharma P. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastrointest. Endosc. 2002;55: 137-139
10. May A, Gossner L, Pech O, et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE). Curative treatment using local endoscopic treatment techniques. Endoscopy 2002;34:604-610
11. Ortner MA, Dorta G, Blum AL, et al. Endoscopic interventions for preneoplastic and neoplastic lesions: mucosectomy, argon plasma coagulation, and photodynamic therapy. Dig. Dis. 2002;20:167-172
12. Ormsby AH, Petras RE, Henricks WH, et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002;51: 671-676
13. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255
14. Werner M, Flejou JF, Hainaut P, et al. Adenocarcinoma of the oesophagus. In Hamilton SR, Aaltonen L, editors, World Health Organization Classification of Tumours: Pathology and Genetics-Tumours of the Digestive System, Lyon, France, IARC Press, 2000;20-25
15. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high grade dysplasia. Gastroenterology 2001;120:1607-1619
16. Steinl HJ. Esophageal cancer: screening and surveillance. Results of consensus conference. Dis. Esoph. 1996;9:3-19
17. Reid BJ, Levine DS, Longton G, et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am. J. Gastroenterol. 2000;95: 1669-1676
18. Collard JM. High-grade dysplasia in Barrett's esophagus. The case for esophagectomy. Chest Surg. Clin. N. Am. 2002;12:77-92
19. Holscher AH, Bollschweiler E, Schneider PM, et al. Early adenocarcinoma in Barrett's oesophagus. Br. J. Surg. 1997;84:1470-1473
20. Headrick JR, Nichols FC, Miller DL, et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann. Thorac. Surg. 2002;73:1697-1703
21. Kirby JD. Quality of life after oesophagectomy: the patients' perspective. Dis. Esoph. 1999;12:168-171
22. Fernando HC, Luketich JD, Buenaventura PO, et al. Outcomes of minimally invasive esophagectomy (MIE) for high-grade dysplasia of the esophagus. Eur. J. Cardiothorac. Surg. 2002;22:1-6
23. Banki F, Mason R, DeMeester SR, et al. Vagal-sparing esophagectomy: a more physiologic alternative. Ann. Surg. 2002;236:324-336
24. Stein HJ, Feith M. Cancer of the esophagus. In Gospodarowicz M, Henson DE, Hutter RVP, editors, Prognostic Factors in Cancer, 2001;237-249
25. Van Sandick JW, van Lanschot JJ, ten Kate FJ, et al. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 2000;88: 2429-2437
26. Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001;120:1630-1639
27. Merendino KA, Dillard DH. The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiological abnormalities at the esophagogastric junction. Ann. Surg. 1955;142:486-506
28. Dresner SM, Lamb PJ, Bennett MK, et al. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001;129:103-109
29. Schroder W, Monig SP, Baldus SE, et al. Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann. Surg. Oncol. 2002;9:807-811
30. Takeshita K, Saito N, Saeki I, et al. Proximal gastrectomy and jejunal pouch interposition for the treatment of early cancer in the upper third of the stomach: surgical techniques and evaluation of postoperative function. Surgery 1997;121:278-286
31. Gaissert HA, Mathisen DJ, Grillo HC, et al. Short-segment intestinal interposition of the distal esophagus. J. Thorac. Cardiovasc. Surg. 1993; 106:860-866
32. Gerzic ZB. Modification of the Merendino procedure. Dis. Esoph. 1997;10:270-275
33. Mansour KA, Bryan FC, Carlson GW. Bowel interposition for esophageal replacement: twenty-five-year experience. Ann. Thorac. Surg. 1997;64:752-756
34. Saeki M, Tsuchida Y, Ogata T, et al. Long-term results of jejunal replacement of the esophagus. J. Pediatr. Surg. 1988;23:483-489
35. Eypasch EP, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br. J. Surg. 1995;82:216-222
36. May A, Gossner L, Pech O, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur. J. Gastroenterol. Hepatol. 2002;14:1085-1091
37. Buttar NS, Wang KK, Lutzke LS, et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest. Endosc. 2001;54:682-838
38. Akiyama H, Tsurumaru M, Ono Y, et al. Esophagectomy without thoracotomy with vagal preservation. J. Am. Coll. Surg. 1994;178:83-85